Dr. Corless develops advanced diagnostic tests for the application of precision medicine. He is an expert on the use of gene sequencing methods to detect cancer and guide treatment, and has expertise in applying molecular diagnostics to the classification and prognostication of solid tumors. Corless has a longstanding research interest in gastrointestinal stromal tumors (GISTs), as well as in bringing new technologies into clinical use. Corless has authored or co-authored more than 250 publications.
Christopher Corless, M.D., Ph.D.
OHSU Knight Cancer Institute Knight Diagnostic Laboratories executive director and chief medical officer; OHSU School of Medicine professor of pathology
Area(s) of expertise:
- Molecular diagnostics
- Gastrointestinal stromal tumors (GISTs)
- Surgical pathology
- SMMART clinical trial platform